BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5
421 results:

  • 1. Columnar Cell thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary thyroid Carcinoma and Follicular Neoplasms.
    Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
    Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Spatial and temporal analysis of thyroid cancer incidence in Guilan Province, Northern Iran, 2009-2018.
    Ghalandari M; Sheikhzade S; Zardosht K; Sadeghi G; Taheri Soodejani M
    Cancer Epidemiol; 2024 Jun; 90():102579. PubMed ID: 38723323
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Risk of Subsequent Primary cancers Among Adult-Onset 5-Year cancer Survivors in South Korea: Retrospective Cohort Study.
    Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
    JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
    Li ZM; Liang ZH; Liu N; Wei KR
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):232-238. PubMed ID: 38494769
    [No Abstract]    [Full Text] [Related]  

  • 5. Clinicopathological features and prognostic value of CD276 expression in female reproductive system malignancies: A meta-analysis.
    Su H; Hao JJ; Xu YB; Zhang FH
    Taiwan J Obstet Gynecol; 2024 Mar; 63(2):154-160. PubMed ID: 38485307
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
    Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
    Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Analyzing cancer Incidence Trends in Oman From 1996 to 2019: A Comprehensive Study of the National cancer Annual Reports.
    Al-Sayegh H; Al-Zadjali S; Al-Moundhri M
    JCO Glob Oncol; 2024 Jan; 10():e2300337. PubMed ID: 38271648
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019.
    Buja A; De Luca G; Zorzi M; Bovo E; Mocellin S; Trevisiol C; Bronte V; Guzzinati S; Rugge M
    Front Public Health; 2023; 11():1267534. PubMed ID: 38259775
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Radiation Dose Does Not Affect the Predictive Value of thyroid Biopsy for Diagnosing Papillary thyroid cancer in a Belarusian Cohort Exposed to Chernobyl Fallout.
    McConnell RJ; Kamysh O; O'Kane PL; Greenebaum E; Rozhko AV; Yauseyenka VV; Minenko VF; Drozdovitch V; Yarets Y; Kukhta T; Mabuchi K; Little MP; Cahoon EK; Zablotska LB
    Acta Cytol; 2024; 68(1):34-44. PubMed ID: 38246154
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genetic predisposition to differentiated thyroid cancer in the Polish population.
    Borowczyk M; Sypniewski M; Szyda J; Braszka M; Ziemnicka K; Ruchała M; Oszywa M; Król ZJ; Dobosz P
    Pol Arch Intern Med; 2024 Mar; 134(3):. PubMed ID: 38165228
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Second primary cancers among females with a first primary breast cancer: a population-based study in Northern Portugal.
    Gonçalves E; Fontes F; Rodrigues JR; Calisto R; Bento MJ; Lunet N; Morais S
    Breast Cancer Res Treat; 2024 Apr; 204(2):367-376. PubMed ID: 38151690
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
    Wang X; Zeng M; Ju X; Lin A; Zhou C; Shen J; Liu Z; Tang B; Cheng Q; Wang Y; Zhang J; Luo P
    Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38055899
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
    Kanankulam Velliangiri S; Ballal S; Prasad Yadhav M; Tripathi M; Satapathy S; Bal C
    PLoS One; 2023; 18(11):e0294343. PubMed ID: 37963164
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Geographic disparities in trends of thyroid cancer incidence and mortality from 1990 to 2019 and a projection to 2030 across income-classified countries and territories.
    Wang C; Wu Z; Lei L; Dong X; Cao W; Luo Z; Zheng Y; Wang F; Xu Y; Zhao L; Shi J; Ren J; Li J; Zhang Y; Chen W; Li N
    J Glob Health; 2023 Sep; 13():04108. PubMed ID: 37766638
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Smoking and alcohol consumption with the risk of 11 common otolaryngological diseases: a bidirectional Mendelian randomization.
    Wang X; Bi Y; Liu G; Wang W; Cui H
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5615-5623. PubMed ID: 37752250
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Long-Term Changes in the Mortality Rates of thyroid cancer in Korea: Analysis of Korean National Data from 1985 to 2020.
    Choi YM; Kim MJ; Lee J; Kwak MK; Jeon MJ; Kim TY; Hong EG; Kim WB; Kim WG
    Endocrinol Metab (Seoul); 2023 Oct; 38(5):588-595. PubMed ID: 37679950
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysis.
    Yang J; Han Y; Min Y; Chen C; Chen J; Xiang K; Liao J; Feng Y; Hu D; Yin G
    Front Endocrinol (Lausanne); 2023; 14():1176512. PubMed ID: 37576962
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.
    Siegel DA; King JB; Lupo PJ; Durbin EB; Tai E; Mills K; Van Dyne E; Buchanan Lunsford N; Henley SJ; Wilson RJ
    J Natl Cancer Inst; 2023 Nov; 115(11):1337-1354. PubMed ID: 37433078
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours.
    Yen CC; Yeh YM; Huang HY; Ting YL; Fu PA; Lin TC; Liu IT; Yen CJ
    Target Oncol; 2023 Jul; 18(4):611-623. PubMed ID: 37347391
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 22.